4QPA | Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Yin, J., Wang, W. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.85 | ||||||||||||
ligand | 35W, NEP | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors., Burdick DJ, Wang S, Heise C, Pan B, Drummond J, Yin J, Goeser L, Magnuson S, Blaney J, Moffat J, Wang W, Chen H, Bioorg Med Chem Lett. 2015 Nov 1;25(21):4728-32. doi: 10.1016/j.bmcl.2015.08.048., Epub 2015 Aug 22. PMID:26338362 |
Data retrieval |
View 4QPA in 3D |
Visual 3D analysis of 4QPA |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4QPA |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |